首页> 外文会议>Advances in Science and Engineering Technology International Conferences >The Use of Fuzzy PROMETHEE Technique in Antiretroviral Combination Decision in Pediatric HIV Treatments
【24h】

The Use of Fuzzy PROMETHEE Technique in Antiretroviral Combination Decision in Pediatric HIV Treatments

机译:模糊PROMETHEE技术在小儿HIV治疗中抗逆转录病毒组合决策中的应用

获取原文

摘要

In this study, we analyzed the best treatment options in HIV pediatric cases among many antiretroviral drug combinations and each combination has different properties. Such many combinations can cause confusion for physicians practice. For this aim, we proposed fuzzy PROMETHEE technique, a multi-criteria decision-making technique based on the mutual comparison of the options. The most common antiretroviral drug combinations used in the pediatric HIV treatments (for the infants and for the children aged less than 3 years) were evaluated and compared corresponding to their parameters by PROMETHEE technique. We used the linguistic fuzzy scale for the importance of the weight of the selected parameters according to experts opinion. Integrase inhibitors based drug combinations (RAL; raltegravir + 3TC/ZDV; lamivudin/zidovudin) was found as best preferred regimes.
机译:在这项研究中,我们分析了许多抗逆转录病毒药物组合中HIV儿科病例的最佳治疗选择,每种组合具有不同的特性。如此众多的组合可能会引起医师实践的困惑。为此,我们提出了模糊PROMETHEE技术,这是一种基于选项相互比较的多准则决策技术。通过PROMETHEE技术评估并比较了儿科HIV治疗中使用的最常见的抗逆转录病毒药物组合(针对婴儿和3岁以下儿童),并根据其参数进行了比较。根据专家的意见,我们使用语言模糊量表来衡量所选参数的权重。发现基于整合酶抑制剂的药物组合(RAL; raltegravir + 3TC / ZDV;拉米夫定/齐多夫定)是最佳方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号